Peihua Lu,Holly A Hill,Lucy J Navsaria et al.
Peihua Lu et al.
B cell malignancies pose challenges due to therapeutic resistance and repeated relapse. Advances in adoptive cellular therapies including chimeric antigen receptor (CAR)-T cells have the potential to transform the treatment landscape in hem...
Immunotherapy for triple-negative breast cancer: A molecular insight into the microenvironment, treatment, and resistance [0.03%]
三阴性乳腺癌免疫治疗：微环境、治疗和耐药性的分子见解
Xupeng Bai,Jie Ni,Julia Beretov et al.
Xupeng Bai et al.
Clinicians have very limited options to treat triple-negative breast cancer (TNBC) due to the lack of effective targeted drugs. Recently, the findings of the mechanism underlying tumor-intrinsic immune escape have fueled a wave of studies i...
Lung cancer risk in non-smoking females with a familial history of cancer: a multi-center prospective cohort study in China [0.03%]
具有家族癌症史的非吸烟女性患肺癌风险：一项在中国多中心开展的前瞻性队列研究
Fei Wang,Fengwei Tan,Zheng Wu et al.
Fei Wang et al.
Familial risk of lung cancer has been widely studied but whether this association holds in non-smoking females is largely unknown. We sought to determine the relationship between a family history of cancer and lung cancer risk among Chinese...
The NCC mathematical modeling framework for decision-making of six major cancers [0.03%]
NCC六种主要癌症的决策数学模型框架
Changfa Xia,Wanqing Chen
Changfa Xia
Objective: Mathematical modeling and simulation is a useful research method to inform decision-making. This article aims to describe the National Cancer Center (NCC) modeling framework and how well it reproduces observed ...
Hu Fang,Johanna Bertl,Xiaoqiang Zhu et al.
Hu Fang et al.
Background: Tumour mutational burden (TMB) has emerged as a predictive marker for responsiveness to immune checkpoint inhibitors (ICI) in multiple tumour types. It can be calculated from somatic mutations detected from wh...
Erratum to 'Evolution and genotypic characteristics of small cell lung cancer transformation in non-small cell lung carcinomas' [Journal of the National Cancer Center, 1 (2021), 4: 153-162] [0.03%]
国家癌症中心杂志关于“小细胞肺癌转化的进化和基因型特征”的勘误通知（卷1，2021年，4期，153-162页）
Jia Zhong,Xiaoting Li,Zhijie Wang et al.
Jia Zhong et al.
[This corrects the article DOI: 10.1016/j.jncc.2021.11.001.]. © 2022 Chinese National Cancer Center. Published by Elsevier B.V.
Published Erratum
Journal of the National Cancer Center. 2022 Dec 24;3(1):92. DOI:10.1016/j.jncc.2022.11.001 2022
Patterns and trends in esophageal cancer incidence and mortality in China: An analysis based on cancer registry data [0.03%]
我国食管癌的发病和死亡分布模式及趋势——基于肿瘤登记数据的分析
Ru Chen,Rongshou Zheng,Siwei Zhang et al.
Ru Chen et al.
Background: Esophageal cancer poses a significant global burden, while its patterns and trends remain to be clarified. The aim of this study is to provide an update on the incidence and mortality rates of esophageal cance...
Personalized precision radiotherapy and its evolving role for human papillomavirus-positive oropharyngeal cancer [0.03%]
人乳头瘤病毒阳性口咽癌的精确放疗及其演变作用
Hayden Ansinelli,Chris Gay,Steven Nguyen et al.
Hayden Ansinelli et al.
Human papilloma virus (HPV)-associated oropharyngeal cancer (OPC) is a unique entity with increased responsiveness to treatment and excellent oncologic outcomes. The purpose of this narrative review is to highlight how an improved prognosis...
Tianhao Shan,Xianhui Ran,Huizhang Li et al.
Tianhao Shan et al.
Background: The stage at diagnosis is a major factor in making treatment strategies and cancer control policies. However, the stage distribution for liver cancer in China was not well studied. In this multi-center hospita...
A global perspective on the ethnic-specific BRCA variation and its implication in clinical application [0.03%]
全球BRCA变异位点概览及其临床应用意义探讨
San Ming Wang
San Ming Wang
Pathogenic BRCA1 and BRCA2 (BRCA) variation is the genetic predisposition for high cancer risk affecting mostly breast and ovarian. BRCA variation information is widely used in clinical diagnosis, treatment, and prevention of BRCA-related c...